Canonical ID: NK-QfFkwcpTeaFHBpwC4e2GeA · Entity type: Company (reference)
| Property | Value | Lang | Source dataset | Source ID | First seen | ||
|---|---|---|---|---|---|---|---|
Organization:address | Ahmed Khair Street, 11111 Khartoum, SUDAN | eu_fsf | eu-fsf-eu-11097-27 | ||||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
Organization:address | Ahmed Khair Street, Khartoum, Sudan, 11111 | eng | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | |||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
LegalEntity:address | Ahmed Khair Street, Khartoum, 11111 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
Organization:address | Ahmed Khair Street, 11111 Khartoum, SUDAN | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:address | Ahmed Khair Street, Khartoum 11111, Soudan | fra | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | |||
Organization:address | Ahmed Khair Street, 11111 Khartoum, Sudan | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Company:address | Sudan (North) | permid | permid-5086676964 | ||||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
Organization:address | Ahmed Khair Street, Khartoum 11111 | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
LegalEntity:address | Ahmed Khair Street, 11111 Khartoum, Sudan | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
Organization:address | Ahmed Khair Street, 11111 Khartoum | eng | us_ofac_sdn | ofac-45288 | |||
LegalEntity:addressEntity | addr-795c2bc9d14fa8d3ca63bacf49c05486ab0eb661 | gb_hmt_sanctions | gb-hmt-16008 | ||||
Organization:addressEntity | addr-7831f5e5a4b15db6451a9a39a9688a36a95cb916 | us_ofac_sdn | ofac-45288 | ||||
LegalEntity:addressEntity | addr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178 | ch_seco_sanctions | ch-seco-73715 | ||||
Organization:addressEntity | addr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178 | eu_fsf | eu-fsf-eu-11097-27 | ||||
Organization:addressEntity | addr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178 | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
LegalEntity:alias | GSK Advance | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:alias | شركة جي أس كيه أدفانس كومباني لميتد | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
LegalEntity:alias | GSK Advance Co. Ltd | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:alias | GSK Advance | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:alias | GSK for Advanced Business Co. Ltd | eng | us_ofac_sdn | ofac-45288 | |||
LegalEntity:alias | GSK Advance Co. Ltd. and GSK for Advanced Business Co. Ltd. | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
LegalEntity:country | sd | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:country | sd | fr_tresor_gels_avoir | fr-ga-7112 | ||||
LegalEntity:country | sd | ch_seco_sanctions | ch-seco-73715 | ||||
Company:country | sd | ext_us_ofac_press_releases | ofac-pr-22d1d81406ff76a00df25177a7ff2a38a67110af | ||||
Organization:country | sd | eu_fsf | eu-fsf-eu-11097-27 | ||||
Company:country | sd | permid | permid-5086676964 | ||||
LegalEntity:country | sd | us_sam_exclusions | usgsa-s4mrvqp60 | ||||
LegalEntity:country | sd | us_sam_exclusions | usgsa-s4mrvqghp | ||||
Organization:country | sd | us_ofac_sdn | ofac-45288 | ||||
Organization:country | sd | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
LegalEntity:country | sd | us_sam_exclusions | usgsa-s4mrvqqh0 | ||||
Organization:country | sd | gb_fcdo_sanctions | gb-fcdo-sud0010 | ||||
LegalEntity:country | sd | gb_hmt_sanctions | gb-hmt-16008 | ||||
LegalEntity:country | sd | us_sam_exclusions | usgsa-s4mrvqhwx | ||||
LegalEntity:createdAt | 2024-04-10 | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:createdAt | 2025-02-13 | us_sam_exclusions | usgsa-s4mrvqghp | ||||
LegalEntity:createdAt | 2025-02-14 | us_sam_exclusions | usgsa-s4mrvqp60 | ||||
LegalEntity:createdAt | 2025-02-14 | us_sam_exclusions | usgsa-s4mrvqqh0 | ||||
LegalEntity:createdAt | 2023-07-12 | gb_hmt_sanctions | gb-hmt-16008 | ||||
LegalEntity:createdAt | 2025-02-13 | us_sam_exclusions | usgsa-s4mrvqhwx | ||||
Organization:id | 15ac8505ea6049f523e4e17d5e03d0df66b8113a | fr_tresor_gels_avoir | fr-ga-7112 | ||||
Organization:id | 2c2c42b4238ac5d9141d33934c648ced68d6b22c | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | ||||
LegalEntity:id | 729ef1e73d5835dbdf63bad56b7f8ba8f8faaff3 | eu_journal_sanctions | eu-oj-5fad1d1ab4d86f861a4a86c7bdd6d47544baee13 | ||||
Organization:id | d6b40ab43bdf3c74f2b8e3cdb03fe8aeb01a638d | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | ||||
LegalEntity:id | 4798ba636e906b6de63340a340fce556dd273b54 | gb_hmt_sanctions | gb-hmt-16008 | ||||
LegalEntity:id | ae0c24f9ebcc0bb0193ec0680f4009d639c3fc57 | gb_hmt_sanctions | gb-hmt-16008 | ||||
LegalEntity:id | 7fdca0cd01475f4f8cb6f0fc384aacbccf42b898 | gb_hmt_sanctions | gb-hmt-16008 | ||||
Organization:id | d927eedc26b54da8b07a75d302aa83bff86d5f00 | eu_fsf | eu-fsf-eu-11097-27 | ||||
LegalEntity:id | b06cd4661a2871ea87eef636c3c1296703074f60 | ch_seco_sanctions | ch-seco-73715 | ||||
Company:id | 6748437721ea5ff49517461a1e585efe7f036d8f | permid | permid-5086676964 | ||||
Company:id | d569d902025e0ce88a466c1848f6e59b4fd1e9d2 | ext_us_ofac_press_releases | ofac-pr-22d1d81406ff76a00df25177a7ff2a38a67110af | ||||
LegalEntity:id | 1e537e07f3d6c47a9666106f19ad1374d407bb9b | us_sam_exclusions | usgsa-s4mrvqghp | ||||
LegalEntity:id | 38f6a01db3486097a406a2bf0d39c3b3dd6e4a99 | us_sam_exclusions | usgsa-s4mrvqhwx | ||||
Organization:id | 10e8ad524d12ca2bac8a4ddaa68d9f81733ec645 | gb_fcdo_sanctions | gb-fcdo-sud0010 | ||||
Organization:id | 1955889075c46fc73cb737596a4ac3a8c4f2381d | gb_fcdo_sanctions | gb-fcdo-sud0010 | ||||
LegalEntity:id | 6bdf626170e588ac7921e215f5e008b60bbdf1e2 | us_sam_exclusions | usgsa-s4mrvqp60 | ||||
Organization:id | dd231b436383d1e5c3dc4cfbb31503bb79e3a49d | gb_fcdo_sanctions | gb-fcdo-sud0010 | ||||
Organization:id | 5b7ac4b9574e21ee374811676c8970299ccffbf2 | gb_fcdo_sanctions | gb-fcdo-sud0010 | ||||
LegalEntity:id | f8a5a1ac2f68d7a2e3edbc7e3658076f92551e2a | us_sam_exclusions | usgsa-s4mrvqqh0 | ||||
Organization:id | f66edd426b44d2cdd599ea0c1bfabce620d2e191 | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:id | 945bc15227070f4b552b7a18c6b043cdf6e2dfec | be_fod_sanctions | be-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3 | ||||
Organization:id | 04681ad63dd5e6b5a7176011e14b906b6d93bab0 | us_ofac_sdn | ofac-45288 | ||||
LegalEntity:id | e10d184d72ac8f85f9f31011542239b3f5b431ac | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:id | d3e12e942d40ccdcf5500199d3af7a90cc44dd2e | us_trade_csl | ofac-45288 | ||||
Company:jurisdiction | sd | permid | permid-5086676964 | ||||
Organization:legalForm | Limited Company | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
LegalEntity:legalForm | Limited Company | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:modifiedAt | 2024-04-10 | ch_seco_sanctions | ch-seco-73715 | ||||
Organization:modifiedAt | 2024-01-22 | eu_fsf | eu-fsf-eu-11097-27 | ||||
Organization:modifiedAt | 2024-01-22 | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
LegalEntity:modifiedAt | 2023-07-12 | gb_hmt_sanctions | gb-hmt-16008 | ||||
LegalEntity:name | GSK ADVANCE COMPANY LTD | eu_journal_sanctions | eu-oj-5fad1d1ab4d86f861a4a86c7bdd6d47544baee13 | ||||
LegalEntity:name | GSK Advance Company Ltd. | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:name | GSK Advance Co. Ltd | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:name | GSK ADVANCE COMPANY LTD | eng | eu_fsf | eu-fsf-eu-11097-27 | |||
Organization:name | GSK Advance Company LTD | eng | us_ofac_sdn | ofac-45288 | |||
Company:name | Gsk Advance Co Ltd | permid | permid-5086676964 | ||||
LegalEntity:name | GSK ADVANCE COMPANY LTD | ch_seco_sanctions | ch-seco-73715 | ||||
Organization:name | GSK ADVANCE COMPANY LTD | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
Organization:name | GSK ADVANCE COMPANY LTD | us_trade_csl | ofac-45288 | ||||
Organization:name | GSK ADVANCE COMPANY LTD | eng | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | |||
LegalEntity:name | GSK Advance Company Ltd | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:name | GSK FOR ADVANCED BUSINESS CO. LTD | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
LegalEntity:name | GSK FOR ADVANCED BUSINESS CO. LTD | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
LegalEntity:name | GSK ADVANCE COMPANY LTD | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
Organization:name | GSK ADVANCE COMPANY LTD | eng | be_fod_sanctions | eu-fsf-eu-11097-27 | |||
Company:name | GSK Advance Company Ltd | eng | ext_us_ofac_press_releases | ofac-pr-22d1d81406ff76a00df25177a7ff2a38a67110af | |||
LegalEntity:name | GSK ADVANCE COMPANY LTD | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
Organization:name | GSK ADVANCE COMPANY LTD | fra | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | |||
Organization:name | GSK ADVANCE COMPANY LTD | be_fod_sanctions | be-fod-deec9d50409099c0bb7f4fffc74ed635088b80b3 | ||||
Organization:name | GSK Advance | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:name | GSK Advance Company Ltd | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
LegalEntity:notes | GSK is a Sudan-based information technology and security company, which is 60 % owned by RSF Major Algoney Hamdan Dagalo, the youngest brother of Mohamed Hamdan Dagalo (Hemedti). GSK is part of the RSF’s commercial network which generates stable revenue for the RSF enabling them to finance and continue the conflict in Sudan. It is used by the RSF as a front company, facilitating cash flows into the RSF and being involved in the RSF’s procurement processes. In addition, since at least 2019, GSK has been working with Aviatrade LLC, a Russia-based military supply company, on the purchase and supply of material and equipment for the benefit of the RSF, including the corresponding training, and on the purchase and supply of unmanned aerial vehicles, monitoring equipment and spare parts. Reconnaissance and weaponised drones are used by the RSF in the conflict in Sudan. Therefore, GSK Advance Company LTD provides support for RSF actions that threaten the peace, stability and security of Sudan. | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:notes | (also GSK FOR ADVANCED BUSINESS CO. LTD, GSK FOR ADVANCED BUSINESS CO. LTD) | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
LegalEntity:notes | (also GSK ADVANCE COMPANY LTD) | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||